Inotiv (NOTVQ) Cash from Operations Growth (1y) (2011 - 2026)
Inotiv (NOTVQ) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 14.65% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 86.90% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 25.34% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 25.96% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -9.63% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -14.10% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.33% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.74% |
| 10 | Inotiv | 348,881.46 | -14.83 Mn | 111.99 Mn | 91.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.65% |
| Dec 31, 2025 | -20.81% |
| Sep 30, 2025 | 703.08% |
| Jun 30, 2025 | 49.70% |
| Mar 31, 2025 | -175.75% |
| Dec 31, 2024 | 31.29% |
| Sep 30, 2024 | -112.64% |
| Jun 30, 2024 | -500.81% |
| Mar 31, 2024 | 31.80% |
| Dec 31, 2023 | 11.67% |
| Sep 30, 2023 | 10,872.51% |
| Jun 30, 2023 | 139.24% |
| Mar 31, 2023 | 148.28% |
| Dec 31, 2022 | -548.29% |
| Sep 30, 2022 | -93.66% |
| Jun 30, 2022 | -367.24% |
| Mar 31, 2022 | 79.89% |
| Dec 31, 2021 | -169.19% |
| Sep 30, 2021 | 1,011.15% |
| Jun 30, 2021 | 184.11% |